Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
1988-1-14
pubmed:abstractText
A reliable liver metastasis model using intraportal injections of sarcoma cells was established in syngeneic hooded Lister rats to study the blood supply of the tumours and to evaluate the role of degradable starch microspheres (DSM) in conjunction with selective hepatic arterial and portal venous chemotherapy. The tumour/normal liver (T/L) ratio after intra-arterial and intraportal injection of 113Sn microspheres was 1.04 (range: 0.38-1.15) and 0.03 (range: 0.006-0.22), respectively. After intravenous 14C-iodoantipyrine quantitative autoradiography of tumour and normal regions demonstrated a mean T/L ratio of 0.74 +/- 0.05. After hepatic artery ligation (HAL) and portal vein ligation (PVL) the values were 0.32 +/- 0.05 and 0.42 +/- 0.05, respectively. These results confirm that the vascularity of the tumours in this model is similar to human colorectal cancer metastases. Radiolabelled 14C 5-Fluorouracil (5-FU) was given intravenously, via the hepatic artery and via the portal vein (the latter two routes with and without DSM). Quantitative autoradiography of tumour regions showed that selective hepatic arterial administration with DSM resulted in a significantly increased concentration of 14C-5-FU within the tumours. These results suggest that DSM may enhance the therapeutic benefit of hepatic arterial 5-FU by increasing its uptake into tumours.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/3678948-13699929, http://linkedlifedata.com/resource/pubmed/commentcorrection/3678948-14268654, http://linkedlifedata.com/resource/pubmed/commentcorrection/3678948-14285938, http://linkedlifedata.com/resource/pubmed/commentcorrection/3678948-2936660, http://linkedlifedata.com/resource/pubmed/commentcorrection/3678948-3780789, http://linkedlifedata.com/resource/pubmed/commentcorrection/3678948-385325, http://linkedlifedata.com/resource/pubmed/commentcorrection/3678948-3893622, http://linkedlifedata.com/resource/pubmed/commentcorrection/3678948-4030927, http://linkedlifedata.com/resource/pubmed/commentcorrection/3678948-5402533, http://linkedlifedata.com/resource/pubmed/commentcorrection/3678948-5450714, http://linkedlifedata.com/resource/pubmed/commentcorrection/3678948-6166362, http://linkedlifedata.com/resource/pubmed/commentcorrection/3678948-623275, http://linkedlifedata.com/resource/pubmed/commentcorrection/3678948-6409491, http://linkedlifedata.com/resource/pubmed/commentcorrection/3678948-6474357, http://linkedlifedata.com/resource/pubmed/commentcorrection/3678948-6498075, http://linkedlifedata.com/resource/pubmed/commentcorrection/3678948-7046907, http://linkedlifedata.com/resource/pubmed/commentcorrection/3678948-7065143
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0017-5749
pubmed:author
pubmed:issnType
Print
pubmed:volume
28
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1201-7
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1987
pubmed:articleTitle
Temporary blood flow stasis with degradable starch microspheres (DSM) for liver metastases in a rat model.
pubmed:affiliation
University Surgical Unit, Southampton General Hospital.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't